Comparative potency of mecillinam and other β-lactam antibiotics against Escherichia coli strains producing different β-lactamases

被引:29
作者
Sougakoff, W [1 ]
Jarlier, V [1 ]
机构
[1] Univ Paris 06, Fac Med Pitie Salpetriere, Lab Rech Mol Antibiot, F-75634 Paris 13, France
关键词
D O I
10.1093/jac/46.suppl_1.9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The activity of mecillinam, a beta-lactam antibiotic with high affinity for Gram-negative penicillin-binding protein 2 (PBP2), was assessed against ampicillin-resistant Escherichia coli strains producing beta-lactamases representing the three molecular classes, A (TEM-1 and -3, SHV-3 and IRT-5), C (AmpC) and D (OXA-3). The antimicrobial activity of mecillinam and other beta-lactam antibiotics was evaluated by determining their MICs on Mueller-Hinton agar. The time course of hydrolysis in crude extracts prepared from the various beta-lactamase-producing strains was also measured and was used to determine the relative rate of hydrolysis and the apparent affinity for ampicillin, cephalothin and mecillinam. When compared with the other beta-lactam antibiotics, mecillinam demonstrated significantly greater antibacterial potency and higher stability to beta-lactamase hydrolysis in TEM-, IRT- and AmpC-producing isolates. These findings confirm that the antimicrobial potency of mecillinam compares favourably with those of the other penicillins included in the present study, suggesting that mecillinam use in the treatment of infections caused by Gram-negative bacteria should be re-evaluated.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 20 条
  • [1] ACAR J, 1991, PATHOL BIOL PARIS, V39, P737
  • [2] Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice?
    Baerheim, A
    Digranes, A
    Hunskaar, S
    [J]. APMIS, 1999, 107 (07) : 676 - 680
  • [3] BemerMelchior P, 1995, PATHOL BIOL, V43, P760
  • [4] Site-directed mutagenesis of residues 164, 170, 171, 179, 220, 237 and 242 in PER-1 β-lactamase hydrolysing expanded-spectrum cephalosporins
    Bouthors, AT
    Delettré, J
    Mugnier, P
    Jarlier, V
    Sougakoff, W
    [J]. PROTEIN ENGINEERING, 1999, 12 (04): : 313 - 318
  • [5] CHARACTERIZATION AND AMINO-ACID-SEQUENCE OF IRT-4, A NOVEL TEM-TYPE ENZYME WITH A DECREASED SUSCEPTIBILITY TO BETA-LACTAMASE INHIBITORS
    BRUN, T
    PEDUZZI, J
    CANICA, MM
    PAUL, G
    NEVOT, P
    BARTHELEMY, M
    LABIA, R
    [J]. FEMS MICROBIOLOGY LETTERS, 1994, 120 (1-2) : 111 - 117
  • [6] Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases
    Canica, MM
    Barthelemy, M
    Gilly, L
    Labia, R
    Krishnamoorthy, R
    Paul, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) : 374 - 378
  • [7] AMDINOCILLIN
    FARRAR, WE
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (03) : 389 - 390
  • [8] INVITRO ACTIVITIES OF BETA-LACTAM AND AMINOGLYCOSIDE ANTIBIOTICS - A COMPARATIVE-STUDY OF 20 PARENTERALLY ADMINISTERED DRUGS
    FASS, RJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1980, 140 (06) : 763 - 768
  • [9] DIVERSITY OF THE MECHANISMS OF RESISTANCE TO BETA-LACTAM ANTIBIOTICS
    FRERE, JM
    JORIS, B
    GRANIER, B
    MATAGNE, A
    JACOB, F
    BOURGUIGNONBELLEFROID, C
    [J]. RESEARCH IN MICROBIOLOGY, 1991, 142 (06) : 705 - 710
  • [10] Increasing frequency of mecillinam-resistant shigella isolates in urban Dhaka and rural Matlab, Bangladesh: a 6 year observation
    Hossain, MA
    Rahman, M
    Ahmed, QS
    Malek, MA
    Sack, RB
    Albert, MJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (01) : 99 - 102